PointState Capital’s iShares Biotechnology ETF IBB Stock Holding History

PointState Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,700	Closed	-$1.57M	–	183
2017 Q4	$1.57M	Hold	14,700	–	–	0.02%	139
2017 Q3	$1.64M	Buy	14,700 +5,100	+53%	+$545K	0.01%	141
2017 Q2	$992K	Buy	+9,600	New	+$945K	0.01%	127
2015 Q4	–	Sell	-10,500	Closed	-$1.06M	–	100
2015 Q3	$1.06M	Buy	10,500 +2,400	+30%	+$288K	0.03%	83
2015 Q2	$996K	Buy	+8,100	New	+$970K	0.01%	139
2015 Q1	–	Sell	-150,000	Closed	-$15.2M	–	132
2014 Q4	$15.2M	Buy	+150,000	New	+$14.6M	0.26%	70

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

PointState Capital's IBB Position: Q1 2018 in Review

PointState Capital sold out of iShares Biotechnology ETF (IBB) in Q1 2018, closing a stake of 14,700 shares — an estimated $1.57M sold.

PointState Capital first reported a position in IBB in Q4 2014 and held it in 6 quarters. The position peaked at $15.2M in Q4 2014. 607 funds tracked by Wall St. Rank hold IBB as of Q1 2018.

PointState Capital reported no remaining iShares Biotechnology ETF position as of Q1 2018 after selling out during the quarter.
PointState Capital sold 14,700 iShares Biotechnology ETF shares in Q1 2018, an estimated $1.57M.
PointState Capital first reported a position in iShares Biotechnology ETF in Q4 2014 and held it in 6 quarters.
PointState Capital's iShares Biotechnology ETF position peaked at $15.2M in Q4 2014.
607 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2018.

Based on PointState Capital's 13F filing for Q1 2018, filed 15 May 2018.